Vaccinium vitis-idaea L. is a plant widely distributed in Heilongjiang Province, and its stem and leaf are used as an anti-inflammatory folk medicine in China from ancient times to treat respiratory system infections.
water and normal foods ad libitum. They were pre-housed for 3 d and were fasted for about 24 h before the experiment Preparation of the Test Samples The dried stems and leaves (1.5 kg) of Vaccinium vitis-idaea were extracted with ethanol (15 l) under reflux for 60 min. The solution was filtered with paper, and the residue was further extracted as the same way. The solutions were mixed and evaporated to dryness in vacuo at 45°C and the ethanol extract of Vaccinium vitis (EEV) was obtained (extract ratio: 15 %). EEV was diluted with water into the suitable concentration at 2.00, 0.250, and 0.125 g of the extract/ml. Arbutin and fraxin were weighted accurately and dissolved in water into the concentration at 12.5 and 6.25 mg/ml, respectively.
Preparation of Blood Sample EEV was orally administered to rats at the dosage of 40 g of the extract/kg, and 1, 2 or 4 h later, 3.0 ml of the blood was collected from portal vein of the rat. The blood was centrifuged at 3500 rpm for 15 min at room temperature, and the serum was obtained. One milliliter of the serum obtained was mixed with 5 ml of methanol and ultrasonicated for 20 min.
The mixture was centrifuged at 3000 rpm for 10 min at room temperature, and the supernatant obtained was evaporated to dryness in vacuo. The residue was reconstituted in 500 ml of methanol and filtrated through 0.45 mm membrane filter (Millipore Co. Ltd., Tokyo), and the aliquot (20 ml) was applied into HPLC.
HPLC Analysis Waters 510 HPLC gradient system equipped with a Waters 991J photodiode array detector and its data processor (Waters, Tokyo) were applied. The HPLC condition was as following: column, Inertsil ODS-2 (4.6ϫ250 mm, GL Science, Tokyo); column temperature, 40°C; mobile phases: linear gradient system of water (A) and acetonitril (B), A/B 100/0 (0 min), 95/5 (20 min), 0/100 (100 min); flow rate, 1 ml/min; detecting wavelength, 200-400 nm; injection volume: 20 ml.
Anti-inflammatory Effects According to the modified method of acetic acid-induced vascular permeability experiment, 4 ) the mice were fasted for 24 h prior to the experiment and the drugs were given orally. 0.1 ml/10 g body weight, and 60 min later, 0.6 % acetic acid in saline was injected i.p. at the same dosage. The mice were sacrificed by cervical dislocation 20 min after the injection of acetic acid, and 10 ml of saline was injected into the peritoneal cavity. And then the washing solutions were collected into test tubes. To clear turbidity due to protein, 0.1 ml of 1 M NaOH solution was added into each tube, and kept 12 h at 4°C
. The absorbance was obtained at 610 nm in a spectrophotometer (Molecular Devices, Sunnyvale, CA, U.S.A.). The vascular permeability was expressed as the optical densities of the solution leaked from the peritoneal cavity.
Phlegm-Removing Experiment All the test samples were given orally 1 h before the i.p. injection of 0.5 ml of 2.5 % phenol red solution in mice. Twenty-five minutes later, the mice were sacrificed by cervical dislocation, and 1.0 ml of 5 % NaHCO 3 was injected into trachea. Then the excretion was drawn from the respiratory tract, and then another 5 ml of 5 % NaHCO 3 was injected again. This procedure was repeated three times, and the excretions were combined. The excretion was centrifuged at 3000 rpm for 10 min, and the supernatants were used for further analyzing. The absorbance of the supernatant of the excretion from trachea was measured at 545 nm in a spectrophotometer. The excretion quantity of phenol red from trachea was expressed as the optical densities of the supernatant.
5)
Anti-coughing Experiment All the test samples were orally given to the mice. After 60 min, each mouse was placed in upset beaker (500 ml) containing a piece of filter paper that was saturated with 25 % ammonium hydroxide, and the latency period and the number of coughing for 3 min were recorded.
Statistics All the numerical data were expressed as the meanϮS.D. and were analyzed by one-way ANOVA followed by Dunnett's post-hoc test. Figure 2 shows the representative HPLC profiles for control serum, EEV and the serum of rat after the oral administration of EEV, respectively. Two distinct peaks were detected in the serum of the rat treated with EEV, which were identified as arbutin and fraxin (Fig. 1) by comparison with the retention times and UV spectrums of the standard compounds.
RESULTS

Identification of the Compounds Absorbed into Blood
Anti-inflammatory Effects
The results were shown in Table 1 . Both arbutin and fraxin have significant anti-inflammatory effect compared with control group (pϽ0.001). Especially the effect of fraxin with higher dosage was similar to that of dexamethasone, and the effect of arbutin was less than that of fraxin.
Phlegm-Removing Experiment
The results were shown in Table 2 . The results were similar to those of anti-inflammatory experiment, and fraxin showed the strongest phlegmremoving effect among three test samples evaluated. The phlegm-removing effect of arbutin was similar to that of ammonium chloride, especially the higher dosage was stronger than that of ammonium chloride Anti-coughing Experiment The results were shown in Table 3 . Both arbutin and fraxin showed significant anticoughing effects compared with control group (pϽ0.001), the effect of fraxin was similar to that of carbetapentane citrate. 
DISCUSSION
Not all the compounds existed in the crude drugs or their prescriptions could be adsorbed into the body, only those being absorbed into blood can show the bioactivity. In order to elucidate the active constituents of crude drugs, we analyzed EEV and the rat serum after the oral administration of EEV by HPLC, the results showed that nine compounds were detected in EEV, but only two of them were mainly detected in the serum under the same HPLC condition, the main compounds absorbed into blood were the original form of arbutin and fraxin. Therefore, these two compounds have the possibility to show the effects related to clinical usage as a folk medicines of the plant. And the other compounds existed in EVV have little chance to show some bioactivities. Since V. vitis-idaea has been used to treat upper respiratory tract infection, 1) this experiment was designed to clarify whether or not these two compounds fraxin and arbutin have the related pharmacological effects to the folk usage.
We studied the anti-inflammatory, anti-coughing and phlegm removing activities of arbutin and fraxin. The results showed that these two compounds could decrease the acetic acid-induced vascular permeability, increase phenol red excretion from trachea, and decrease the number of ammoniainduced coughing, that demonstrated significant anti-inflammatory, anti-cough and phlegm-removing properties in experimental animal. It was reported that arbutin has a strong superoxide and hydroxyl radical scavenging ability, 6) and as a coumarin derivatives, fraxin should possess anti-inflammatory property.
Therefore it would be concluded that arbutin and fraxin are the bioactive compounds representing the clinical usage of V. vitis-idaea L. 
